×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
A Regulator's View on the Future Vision for Pharmacovigilance
Session Chair(s)
Representative Invited
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
This session will explore perspectives on the future vision for pharmacovigilance. Examining how advances in technology and science can be leveraged to protect patient safety and will discuss what progress is being made against these ambitions.
Learning Objective : Evaluate developments in technology being implemented by regulators to advance safety and surveillance of medicinal products; Discuss the importance of pharmacogenomics for introducing better risk mitigation strategies; Assess opportunities for better ways of working across different stakeholders in pharmacovigilance.
Speaker(s)
Panelist
Representative Invited
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Panelist
Representative Invited
FDA, United States
Have an account?